Crescent Biopharma, Inc.CBIONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-71.53M
↓ 64% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-43.55M
Historical baseline
PeriodValueYoY Change
2025$-71.53M-130.0%
2024$-31.10M+10.8%
2023$-34.88M+24.9%
2022$-46.46M+19.2%
2021$-57.49M-46.5%
2020$-39.24M+24.5%
2019$-51.98M-20.0%
2018$-43.33M-45.6%
2017$-29.77M-0.1%
2016$-29.73M-